Gadobutrol and Paleness - a phase IV clinical study of FDA data

Summary:

Paleness is reported as a side effect among people who take Gadobutrol (gadobutrol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Atenolol, and have Abdominal pain upper.

The phase IV clinical study analyzes which people have Paleness when taking Gadobutrol. It is created by eHealthMe based on reports of 811 people who have side effects when taking Gadobutrol from the FDA, and is updated regularly.

What is Gadobutrol?

Gadobutrol has active ingredients of gadobutrol. eHealthMe is studying from 811 Gadobutrol users. Check the latest studies of Gadobutrol.

What is Paleness?

Paleness (unusual lightness of skin colour) is found to be associated with 1,552 drugs and 2,119 conditions by eHealthMe. Check the latest studies of Paleness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 04, 2026

811 people reported to have side effects when taking Gadobutrol.
Among them, 13 people (1.6%) have Paleness.

Among these 13 people:

How long have people been on Gadobutrol when they have Paleness? *

What is the gender of people who have Paleness when taking Gadobutrol? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Paleness when taking Gadobutrol? *

What are other drugs people take besides Gadobutrol? *

Micardis: 3 people, 23.08%
Calcium Carbonate: 3 people, 23.08%
Atenolol: 3 people, 23.08%
Solu-Medrol: 1 person, 7.69%
Promethazine: 1 person, 7.69%

What are other side effects people have besides Paleness? *

Hypotension (abnormally low blood pressure): 7 people, 53.85%
Dyspnea (difficult or laboured breathing): 6 people, 46.15%
Nausea (feeling of having an urge to vomit): 6 people, 46.15%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 23.08%
Presyncope: 3 people, 23.08%
Contrast Media Reaction (reaction associated with the use of intravenous contrast material during radiology): 3 people, 23.08%
Nausea And Vomiting: 3 people, 23.08%
Lactic Acidosis (low ph in body tissues): 3 people, 23.08%
Cardiac Arrest: 3 people, 23.08%
Peripheral Circulatory Failure: 3 people, 23.08%

What are the existing conditions these people have? *

Abdominal Pain Upper: 2 people, 15.38%
Prostate Cancer: 1 person, 7.69%
Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 7.69%
Meningioma (a diverse set of tumours arising from the meninges): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gadobutrol and have Paleness?

- Check whether Paleness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gadobutrol:

Gadobutrol (811 reports)

Paleness treatments and more:

Paleness (34,670 reports)

Browse all side effects of Gadobutrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paleness:

Paleness (1,552 drugs)

Browse all the conditions that are associated with Paleness:

Paleness (2,119 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadobutrol (the active ingredients of Gadobutrol) and Gadobutrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.